Ixekizumab vs Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Head-to-Head Comparison of Ixekizumab vs. Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis: 24-Week Efficacy and Safety Results From a Randomized, Double-Blinded Trial
Br J Dermatol 2020 Sep 02;[EPub Ahead of Print], A Blauvelt, C Leonardi, B Elewski, JJ Crowley, LC Guenther, M Gooderham, RG Langley, R Vender, A Pinter, CEM Griffiths, Y Tada, H Elmaraghy, RG Lima, G Gallo, L Renda, R Burge, SY Park, B Zhu, K PappFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.